IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Wolfgang Frohlich

USPTO Granted Patents = 13

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:

goldMedal12 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 1 
 
Schering Aktiengesellscaft
 patent

Years Active: 1993-2002

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6340706 - Leukotriene-B4 derivatives, in particular 7-methylcyclohexyl-LTB4 antagonists (2002-01-22),
2. 6160012 - Leukotriene B.sub.4 derivatives, in particular oximo-LTB.sub.4 - (2000-12-12),
3. 5880126 - 9H-Pyridu ((3,4-b) indole derivatives (1999-03-09),
4. 5859054 - Leukotriene B4 derivatives, process for their production and their use (1999-01-12),
5. 5783602 - Leukotriene-B4 derivatives, process for their production and their use (1998-07-21),
6. 5614634 - Leukotriene-B4 derivatives, process for their production and their use (1997-03-25),
7. 5541202 - New leukotriene-B4 Antagonists and their use as pharmaceutical agents (1996-07-30),
8. 5440044 - Leukotriene-B.sub.4 derivatives, process for their production and their (1995-08-08),
9. 5414016 - New leukotriene-B.sub.4 derivatives, process for their production and (1995-05-09),
10. 5352701 - Leukotriene-B.sub.4 antagonist compounds and their use as pharmaceutical (1994-10-04),
11. 5196570 - Leukotriene-B.sub.4 derivatives, process for their production and their (1993-03-23),
12. 5187286 - Leukotriene-B4 derivatives, process for their production and their use (1993-02-16),
13. 5183925 - Leukotriene-B4 derivatives, process for their production and their use (1993-02-02),

Title: Exploring the Innovations of Wolfgang Frohlich in Pharmaceutical Chemistry

Introduction

Wolfgang Frohlich, an accomplished inventor based in Berlin, Germany, holds an impressive portfolio of 13 patents. His work in pharmaceutical chemistry, particularly in the development of leukotriene B4 derivatives, has significantly contributed to the field of medicinal research.

Latest Patents

Among his latest innovations, Frohlich has focused on leukotriene-B4 derivatives, including the development of 7-methylcyclohexyl-LTB4 antagonists. These inventions relate to leukotriene B derivatives of a general formula in which various organic groups and chemical structures play critical roles in their function. Notably, these derivatives can be utilized as pharmaceutical preparations due to their physiologically compatible bases and potential therapeutic applications.

Career Highlights

Frohlich's career includes pivotal roles at Schering Aktiengesellschaft, a company renowned for its innovations in pharmaceuticals. His extensive experience in this institution has allowed him to refine his expertise and contribute to multiple successful research projects. The impact of his work in the pharmaceutical industry is reflected in the patents he has acquired over the years.

Collaborations

Throughout his career, Wolfgang Frohlich has collaborated with esteemed professionals in the field, including Werner Skuballa and Bernd Buchmann. These collaborations have enriched his work and facilitated the advancement of significant research in pharmaceutical chemistry.

Conclusion

Wolfgang Frohlich stands out as a notable inventor whose research and patents have paved the way for advancements in pharmaceutical treatments. His contributions to the development of leukotriene B4 derivatives are particularly significant, showcasing his commitment and innovation in the realm of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…